Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Niurys de Castro Suárez"'
Autor:
Gledys Reynaldo Fernández, Eduardo M. Fernández-Sánchez, Mayra Ramos Suzarte, Daniel Amaro, Roberto Menéndez, Helena Colom, Víctor Mangas-Sanjuan, Gilberto Castañeda, Jorge Duconge, Braulio Jiménez-Vélez, Niurys de Castro Suárez, Carmen Viada, Joaquín Solazábal, María de los A. Bécquer
Publikováno v:
Anales de la Academia de Ciencias de Cuba, Vol 10, Iss 3 (2020)
Introducción. La farmacometría es una disciplina científica vibrante que está conformada por el ciclo de excelencia: integración, innovación e impacto. Objetivo: Evaluar diferentes enfoques farmacométricos en tres productos biotecnológicos cu
Externí odkaz:
https://doaj.org/article/2596f3b4e5dc4692a1fa199da1097f0c
Autor:
Niurys de Castro-Suárez, Mirjam N. Trame, Mayra Ramos-Suzarte, José M. Dávalos, Raymed A. Bacallao-Mendez, Anaelys R. Maceo-Sinabele, Víctor Mangas-Sanjuán, Gledys Reynaldo-Fernández, Leyanis Rodríguez-Vera
Publikováno v:
Pharmaceutics, Vol 12, Iss 12, p 1147 (2020)
Autosomal dominant polycystic kidney disease (ADPKD) is a genetic disease characterized by an overexpression of epidermal growth factor receptor (EGFR). Nimotuzumab is a recombinant humanized monoclonal antibody against human EGFR. The aim of this st
Externí odkaz:
https://doaj.org/article/972aabe181b8495eac84e5c33068ba8d
Autor:
Mirjam N. Trame, Leyanis Rodríguez-Vera, Raymed A. Bacallao-Méndez, Niurys de Castro-Suárez, Anaelys R. Maceo-Sinabele, Victor Mangas-Sanjuan, Mayra Ramos-Suzarte, Jose M. Davalos, Gledys Reynaldo-Fernández
Publikováno v:
Pharmaceutics, Vol 12, Iss 1147, p 1147 (2020)
Pharmaceutics
Volume 12
Issue 12
Pharmaceutics
Volume 12
Issue 12
Autosomal dominant polycystic kidney disease (ADPKD) is a genetic disease characterized by an overexpression of epidermal growth factor receptor (EGFR). Nimotuzumab is a recombinant humanized monoclonal antibody against human EGFR. The aim of this st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b4a4b4d4fa0cc75d2fff9202b17e228
https://www.mdpi.com/1999-4923/12/12/1147
https://www.mdpi.com/1999-4923/12/12/1147
Autor:
Leyanis Rodriguez Vera, Niurys de Castro Suárez, Jorge Luis Soriano, Mayra Ramoz Suzarte, Eduardo Fernández Sánchez, Gilberto Castañeda, Helena Colom Codina
Publikováno v:
Proceedings for Annual Meeting of The Japanese Pharmacological Society. :PO1-8
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c43a6220f1601f63f41268ad7b6380bc
https://doi.org/10.1254/jpssuppl.wcp2018.0_po1-8-42
https://doi.org/10.1254/jpssuppl.wcp2018.0_po1-8-42
Autor:
Mayra Ramos Suzarte, Carlos Villegas, Raymed Bacallao, Niurys de Castro-Suárez, Patricia Lorenzo Luaces, Leyanis Rodriguez Vera, Jose M. Davalos
Publikováno v:
Proceedings for Annual Meeting of The Japanese Pharmacological Society. :PO1-11
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5606f2bfb447666fddf2cc8171f33135
https://doi.org/10.1254/jpssuppl.wcp2018.0_po1-11-8
https://doi.org/10.1254/jpssuppl.wcp2018.0_po1-11-8
Autor:
José M. Dávalos-Iglesias, Carlos Villegas, Christian Leyva-de la Torre, Raymed A. Bacallao-Méndez, Mayelin Troche-Concepción, Betsy Llerena-Ferrer, Niurys de Castro-Suárez, Patricia Lorenzo Luaces, Mayra Ramos-Suzarte, Leyanis Rodríguez-Vera
Publikováno v:
Journal of clinical pharmacology. 59(6)
Autosomal dominant polycystic kidney disease (ADPKD) is a genetic disease characterized by an overexpression and mislocalization of epidermal growth factor receptor (EGFR) to the apical membranes of cystic epithelial cells. Nimotuzumab is a humanized
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f0a7d80c83809c4599a80b2398efc22
https://pubmed.ncbi.nlm.nih.gov/30633365
https://pubmed.ncbi.nlm.nih.gov/30633365
Autor:
Leyanis Rodríguez-Vera, Carlos Orlando Jacobo‐Cabral, Helena Colom Codina, Concepción Peraire Guitart, Niurys de Castro Suárez, Mayra Ramos-Suzarte, Eduardo Fernández-Sánchez, Jorge Luis Soriano, Gilberto Castañeda Hernández
Publikováno v:
Journal of clinical pharmacology. 55(8)
This study aimed (1) to develop a semimechanistic pharmacokinetic (PK) model for nimotuzumab in patients with advanced breast cancer and (2) to identify demographic, biochemical, and clinical predictive factors of the PK variability. Data from a phas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d2655d32d728594007825ae0b2388f5
https://pubmed.ncbi.nlm.nih.gov/25760761
https://pubmed.ncbi.nlm.nih.gov/25760761